Prostate Specific Antigen (PSA) Biomarker Market, Global Outlook and Forecast 2022-2028

March 2022 | 62 pages | ID: P6EF85CBE4DDEN
Market Monitor Global

Abstracts

Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland. The PSA test measures the level of PSA in a man's blood. For this test, a blood sample is sent to a laboratory for analysis.

This report contains market size and forecasts of Prostate Specific Antigen (PSA) Biomarker in Global, including the following market information:

Global Prostate Specific Antigen (PSA) Biomarker Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Prostate Specific Antigen (PSA) Biomarker market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Blood Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Prostate Specific Antigen (PSA) Biomarker include Abbott, Siemens Healthcare, DiaSorin, Roche, Tosoh Bioscience, Fujirebio, BodiTech, GE Healthcare and Endocare, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prostate Specific Antigen (PSA) Biomarker companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Prostate Specific Antigen (PSA) Biomarker Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Prostate Specific Antigen (PSA) Biomarker Market Segment Percentages, by Type, 2021 (%)

• Blood
• Semen
• Urine

Global Prostate Specific Antigen (PSA) Biomarker Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Prostate Specific Antigen (PSA) Biomarker Market Segment Percentages, by Application, 2021 (%)

• Diagnostics
• Drug Discovery
• Personalized Medicine
• Others

Global Prostate Specific Antigen (PSA) Biomarker Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Prostate Specific Antigen (PSA) Biomarker Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Prostate Specific Antigen (PSA) Biomarker revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Prostate Specific Antigen (PSA) Biomarker revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott
• Siemens Healthcare
• DiaSorin
• Roche
• Tosoh Bioscience
• Fujirebio
• BodiTech
• GE Healthcare
• Endocare
• Quest Diagnostics
• Bio-Rad Laboratories
• QIAGEN
• Myriad RBM

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Prostate Specific Antigen (PSA) Biomarker Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Prostate Specific Antigen (PSA) Biomarker Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PROSTATE SPECIFIC ANTIGEN (PSA) BIOMARKER OVERALL MARKET SIZE

2.1 Global Prostate Specific Antigen (PSA) Biomarker Market Size: 2021 VS 2028
2.2 Global Prostate Specific Antigen (PSA) Biomarker Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Prostate Specific Antigen (PSA) Biomarker Players in Global Market
3.2 Top Global Prostate Specific Antigen (PSA) Biomarker Companies Ranked by Revenue
3.3 Global Prostate Specific Antigen (PSA) Biomarker Revenue by Companies
3.4 Top 3 and Top 5 Prostate Specific Antigen (PSA) Biomarker Companies in Global Market, by Revenue in 2021
3.5 Global Companies Prostate Specific Antigen (PSA) Biomarker Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Specific Antigen (PSA) Biomarker Players in Global Market
  3.6.1 List of Global Tier 1 Prostate Specific Antigen (PSA) Biomarker Companies
  3.6.2 List of Global Tier 2 and Tier 3 Prostate Specific Antigen (PSA) Biomarker Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Prostate Specific Antigen (PSA) Biomarker Market Size Markets, 2021 & 2028
  4.1.2 Blood
  4.1.3 Semen
  4.1.4 Urine
4.2 By Type - Global Prostate Specific Antigen (PSA) Biomarker Revenue & Forecasts
  4.2.1 By Type - Global Prostate Specific Antigen (PSA) Biomarker Revenue, 2017-2022
  4.2.2 By Type - Global Prostate Specific Antigen (PSA) Biomarker Revenue, 2023-2028
  4.2.3 By Type - Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Prostate Specific Antigen (PSA) Biomarker Market Size, 2021 & 2028
  5.1.2 Diagnostics
  5.1.3 Drug Discovery
  5.1.4 Personalized Medicine
  5.1.5 Others
5.2 By Application - Global Prostate Specific Antigen (PSA) Biomarker Revenue & Forecasts
  5.2.1 By Application - Global Prostate Specific Antigen (PSA) Biomarker Revenue, 2017-2022
  5.2.2 By Application - Global Prostate Specific Antigen (PSA) Biomarker Revenue, 2023-2028
  5.2.3 By Application - Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Prostate Specific Antigen (PSA) Biomarker Market Size, 2021 & 2028
6.2 By Region - Global Prostate Specific Antigen (PSA) Biomarker Revenue & Forecasts
  6.2.1 By Region - Global Prostate Specific Antigen (PSA) Biomarker Revenue, 2017-2022
  6.2.2 By Region - Global Prostate Specific Antigen (PSA) Biomarker Revenue, 2023-2028
  6.2.3 By Region - Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Prostate Specific Antigen (PSA) Biomarker Revenue, 2017-2028
  6.3.2 US Prostate Specific Antigen (PSA) Biomarker Market Size, 2017-2028
  6.3.3 Canada Prostate Specific Antigen (PSA) Biomarker Market Size, 2017-2028
  6.3.4 Mexico Prostate Specific Antigen (PSA) Biomarker Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Prostate Specific Antigen (PSA) Biomarker Revenue, 2017-2028
  6.4.2 Germany Prostate Specific Antigen (PSA) Biomarker Market Size, 2017-2028
  6.4.3 France Prostate Specific Antigen (PSA) Biomarker Market Size, 2017-2028
  6.4.4 U.K. Prostate Specific Antigen (PSA) Biomarker Market Size, 2017-2028
  6.4.5 Italy Prostate Specific Antigen (PSA) Biomarker Market Size, 2017-2028
  6.4.6 Russia Prostate Specific Antigen (PSA) Biomarker Market Size, 2017-2028
  6.4.7 Nordic Countries Prostate Specific Antigen (PSA) Biomarker Market Size, 2017-2028
  6.4.8 Benelux Prostate Specific Antigen (PSA) Biomarker Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Prostate Specific Antigen (PSA) Biomarker Revenue, 2017-2028
  6.5.2 China Prostate Specific Antigen (PSA) Biomarker Market Size, 2017-2028
  6.5.3 Japan Prostate Specific Antigen (PSA) Biomarker Market Size, 2017-2028
  6.5.4 South Korea Prostate Specific Antigen (PSA) Biomarker Market Size, 2017-2028
  6.5.5 Southeast Asia Prostate Specific Antigen (PSA) Biomarker Market Size, 2017-2028
  6.5.6 India Prostate Specific Antigen (PSA) Biomarker Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Prostate Specific Antigen (PSA) Biomarker Revenue, 2017-2028
  6.6.2 Brazil Prostate Specific Antigen (PSA) Biomarker Market Size, 2017-2028
  6.6.3 Argentina Prostate Specific Antigen (PSA) Biomarker Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Revenue, 2017-2028
  6.7.2 Turkey Prostate Specific Antigen (PSA) Biomarker Market Size, 2017-2028
  6.7.3 Israel Prostate Specific Antigen (PSA) Biomarker Market Size, 2017-2028
  6.7.4 Saudi Arabia Prostate Specific Antigen (PSA) Biomarker Market Size, 2017-2028
  6.7.5 UAE Prostate Specific Antigen (PSA) Biomarker Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Abbott
  7.1.1 Abbott Corporate Summary
  7.1.2 Abbott Business Overview
  7.1.3 Abbott Prostate Specific Antigen (PSA) Biomarker Major Product Offerings
  7.1.4 Abbott Prostate Specific Antigen (PSA) Biomarker Revenue in Global Market (2017-2022)
  7.1.5 Abbott Key News
7.2 Siemens Healthcare
  7.2.1 Siemens Healthcare Corporate Summary
  7.2.2 Siemens Healthcare Business Overview
  7.2.3 Siemens Healthcare Prostate Specific Antigen (PSA) Biomarker Major Product Offerings
  7.2.4 Siemens Healthcare Prostate Specific Antigen (PSA) Biomarker Revenue in Global Market (2017-2022)
  7.2.5 Siemens Healthcare Key News
7.3 DiaSorin
  7.3.1 DiaSorin Corporate Summary
  7.3.2 DiaSorin Business Overview
  7.3.3 DiaSorin Prostate Specific Antigen (PSA) Biomarker Major Product Offerings
  7.3.4 DiaSorin Prostate Specific Antigen (PSA) Biomarker Revenue in Global Market (2017-2022)
  7.3.5 DiaSorin Key News
7.4 Roche
  7.4.1 Roche Corporate Summary
  7.4.2 Roche Business Overview
  7.4.3 Roche Prostate Specific Antigen (PSA) Biomarker Major Product Offerings
  7.4.4 Roche Prostate Specific Antigen (PSA) Biomarker Revenue in Global Market (2017-2022)
  7.4.5 Roche Key News
7.5 Tosoh Bioscience
  7.5.1 Tosoh Bioscience Corporate Summary
  7.5.2 Tosoh Bioscience Business Overview
  7.5.3 Tosoh Bioscience Prostate Specific Antigen (PSA) Biomarker Major Product Offerings
  7.5.4 Tosoh Bioscience Prostate Specific Antigen (PSA) Biomarker Revenue in Global Market (2017-2022)
  7.5.5 Tosoh Bioscience Key News
7.6 Fujirebio
  7.6.1 Fujirebio Corporate Summary
  7.6.2 Fujirebio Business Overview
  7.6.3 Fujirebio Prostate Specific Antigen (PSA) Biomarker Major Product Offerings
  7.6.4 Fujirebio Prostate Specific Antigen (PSA) Biomarker Revenue in Global Market (2017-2022)
  7.6.5 Fujirebio Key News
7.7 BodiTech
  7.7.1 BodiTech Corporate Summary
  7.7.2 BodiTech Business Overview
  7.7.3 BodiTech Prostate Specific Antigen (PSA) Biomarker Major Product Offerings
  7.7.4 BodiTech Prostate Specific Antigen (PSA) Biomarker Revenue in Global Market (2017-2022)
  7.7.5 BodiTech Key News
7.8 GE Healthcare
  7.8.1 GE Healthcare Corporate Summary
  7.8.2 GE Healthcare Business Overview
  7.8.3 GE Healthcare Prostate Specific Antigen (PSA) Biomarker Major Product Offerings
  7.8.4 GE Healthcare Prostate Specific Antigen (PSA) Biomarker Revenue in Global Market (2017-2022)
  7.8.5 GE Healthcare Key News
7.9 Endocare
  7.9.1 Endocare Corporate Summary
  7.9.2 Endocare Business Overview
  7.9.3 Endocare Prostate Specific Antigen (PSA) Biomarker Major Product Offerings
  7.9.4 Endocare Prostate Specific Antigen (PSA) Biomarker Revenue in Global Market (2017-2022)
  7.9.5 Endocare Key News
7.10 Quest Diagnostics
  7.10.1 Quest Diagnostics Corporate Summary
  7.10.2 Quest Diagnostics Business Overview
  7.10.3 Quest Diagnostics Prostate Specific Antigen (PSA) Biomarker Major Product Offerings
  7.10.4 Quest Diagnostics Prostate Specific Antigen (PSA) Biomarker Revenue in Global Market (2017-2022)
  7.10.5 Quest Diagnostics Key News
7.11 Bio-Rad Laboratories
  7.11.1 Bio-Rad Laboratories Corporate Summary
  7.11.2 Bio-Rad Laboratories Business Overview
  7.11.3 Bio-Rad Laboratories Prostate Specific Antigen (PSA) Biomarker Major Product Offerings
  7.11.4 Bio-Rad Laboratories Prostate Specific Antigen (PSA) Biomarker Revenue in Global Market (2017-2022)
  7.11.5 Bio-Rad Laboratories Key News
7.12 QIAGEN
  7.12.1 QIAGEN Corporate Summary
  7.12.2 QIAGEN Business Overview
  7.12.3 QIAGEN Prostate Specific Antigen (PSA) Biomarker Major Product Offerings
  7.12.4 QIAGEN Prostate Specific Antigen (PSA) Biomarker Revenue in Global Market (2017-2022)
  7.12.5 QIAGEN Key News
7.13 Myriad RBM
  7.13.1 Myriad RBM Corporate Summary
  7.13.2 Myriad RBM Business Overview
  7.13.3 Myriad RBM Prostate Specific Antigen (PSA) Biomarker Major Product Offerings
  7.13.4 Myriad RBM Prostate Specific Antigen (PSA) Biomarker Revenue in Global Market (2017-2022)
  7.13.5 Myriad RBM Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Prostate Specific Antigen (PSA) Biomarker Market Opportunities & Trends in Global Market
Table 2. Prostate Specific Antigen (PSA) Biomarker Market Drivers in Global Market
Table 3. Prostate Specific Antigen (PSA) Biomarker Market Restraints in Global Market
Table 4. Key Players of Prostate Specific Antigen (PSA) Biomarker in Global Market
Table 5. Top Prostate Specific Antigen (PSA) Biomarker Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Prostate Specific Antigen (PSA) Biomarker Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Prostate Specific Antigen (PSA) Biomarker Revenue Share by Companies, 2017-2022
Table 8. Global Companies Prostate Specific Antigen (PSA) Biomarker Product Type
Table 9. List of Global Tier 1 Prostate Specific Antigen (PSA) Biomarker Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Specific Antigen (PSA) Biomarker Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Prostate Specific Antigen (PSA) Biomarker Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Prostate Specific Antigen (PSA) Biomarker Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Prostate Specific Antigen (PSA) Biomarker Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Prostate Specific Antigen (PSA) Biomarker Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Prostate Specific Antigen (PSA) Biomarker Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Prostate Specific Antigen (PSA) Biomarker Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Corporate Summary
Table 31. Abbott Prostate Specific Antigen (PSA) Biomarker Product Offerings
Table 32. Abbott Prostate Specific Antigen (PSA) Biomarker Revenue (US$, Mn), (2017-2022)
Table 33. Siemens Healthcare Corporate Summary
Table 34. Siemens Healthcare Prostate Specific Antigen (PSA) Biomarker Product Offerings
Table 35. Siemens Healthcare Prostate Specific Antigen (PSA) Biomarker Revenue (US$, Mn), (2017-2022)
Table 36. DiaSorin Corporate Summary
Table 37. DiaSorin Prostate Specific Antigen (PSA) Biomarker Product Offerings
Table 38. DiaSorin Prostate Specific Antigen (PSA) Biomarker Revenue (US$, Mn), (2017-2022)
Table 39. Roche Corporate Summary
Table 40. Roche Prostate Specific Antigen (PSA) Biomarker Product Offerings
Table 41. Roche Prostate Specific Antigen (PSA) Biomarker Revenue (US$, Mn), (2017-2022)
Table 42. Tosoh Bioscience Corporate Summary
Table 43. Tosoh Bioscience Prostate Specific Antigen (PSA) Biomarker Product Offerings
Table 44. Tosoh Bioscience Prostate Specific Antigen (PSA) Biomarker Revenue (US$, Mn), (2017-2022)
Table 45. Fujirebio Corporate Summary
Table 46. Fujirebio Prostate Specific Antigen (PSA) Biomarker Product Offerings
Table 47. Fujirebio Prostate Specific Antigen (PSA) Biomarker Revenue (US$, Mn), (2017-2022)
Table 48. BodiTech Corporate Summary
Table 49. BodiTech Prostate Specific Antigen (PSA) Biomarker Product Offerings
Table 50. BodiTech Prostate Specific Antigen (PSA) Biomarker Revenue (US$, Mn), (2017-2022)
Table 51. GE Healthcare Corporate Summary
Table 52. GE Healthcare Prostate Specific Antigen (PSA) Biomarker Product Offerings
Table 53. GE Healthcare Prostate Specific Antigen (PSA) Biomarker Revenue (US$, Mn), (2017-2022)
Table 54. Endocare Corporate Summary
Table 55. Endocare Prostate Specific Antigen (PSA) Biomarker Product Offerings
Table 56. Endocare Prostate Specific Antigen (PSA) Biomarker Revenue (US$, Mn), (2017-2022)
Table 57. Quest Diagnostics Corporate Summary
Table 58. Quest Diagnostics Prostate Specific Antigen (PSA) Biomarker Product Offerings
Table 59. Quest Diagnostics Prostate Specific Antigen (PSA) Biomarker Revenue (US$, Mn), (2017-2022)
Table 60. Bio-Rad Laboratories Corporate Summary
Table 61. Bio-Rad Laboratories Prostate Specific Antigen (PSA) Biomarker Product Offerings
Table 62. Bio-Rad Laboratories Prostate Specific Antigen (PSA) Biomarker Revenue (US$, Mn), (2017-2022)
Table 63. QIAGEN Corporate Summary
Table 64. QIAGEN Prostate Specific Antigen (PSA) Biomarker Product Offerings
Table 65. QIAGEN Prostate Specific Antigen (PSA) Biomarker Revenue (US$, Mn), (2017-2022)
Table 66. Myriad RBM Corporate Summary
Table 67. Myriad RBM Prostate Specific Antigen (PSA) Biomarker Product Offerings
Table 68. Myriad RBM Prostate Specific Antigen (PSA) Biomarker Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Prostate Specific Antigen (PSA) Biomarker Segment by Type in 2021
Figure 2. Prostate Specific Antigen (PSA) Biomarker Segment by Application in 2021
Figure 3. Global Prostate Specific Antigen (PSA) Biomarker Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Prostate Specific Antigen (PSA) Biomarker Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Prostate Specific Antigen (PSA) Biomarker Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prostate Specific Antigen (PSA) Biomarker Revenue in 2021
Figure 8. By Type - Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share, 2017-2028
Figure 9. By Application - Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share, 2017-2028
Figure 10. By Region - Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share, 2017-2028
Figure 11. By Country - North America Prostate Specific Antigen (PSA) Biomarker Revenue Market Share, 2017-2028
Figure 12. US Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Prostate Specific Antigen (PSA) Biomarker Revenue Market Share, 2017-2028
Figure 16. Germany Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2017-2028
Figure 17. France Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Prostate Specific Antigen (PSA) Biomarker Revenue Market Share, 2017-2028
Figure 24. China Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2017-2028
Figure 28. India Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Prostate Specific Antigen (PSA) Biomarker Revenue Market Share, 2017-2028
Figure 30. Brazil Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Revenue Market Share, 2017-2028
Figure 33. Turkey Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Prostate Specific Antigen (PSA) Biomarker Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Prostate Specific Antigen (PSA) Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Siemens Healthcare Prostate Specific Antigen (PSA) Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. DiaSorin Prostate Specific Antigen (PSA) Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Roche Prostate Specific Antigen (PSA) Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Tosoh Bioscience Prostate Specific Antigen (PSA) Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Fujirebio Prostate Specific Antigen (PSA) Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. BodiTech Prostate Specific Antigen (PSA) Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. GE Healthcare Prostate Specific Antigen (PSA) Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Endocare Prostate Specific Antigen (PSA) Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Quest Diagnostics Prostate Specific Antigen (PSA) Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Bio-Rad Laboratories Prostate Specific Antigen (PSA) Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. QIAGEN Prostate Specific Antigen (PSA) Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Myriad RBM Prostate Specific Antigen (PSA) Biomarker Revenue Year Over Year Growth (US$, Mn) & (2017-2022)